DNAY News and Press, Codex DNA Inc. From 03/16/22

Gainers: Semtech Corporation (NASDAQ:SMTC) +4%. Forterra (NASDAQ:FRTA) +4%. Cerus Corporation (NASDAQ:CERS) +4%. Inspirato Incorporated (NASDAQ:ISPO) +4%. Infinera Corporation (NASDAQ:INFN) +4%. Losers: Codex DNA (NASDAQ:DNAY) -6%. CureVac  (NASDAQ:CVAC) -5%. CarParts...

SAN DIEGO, March 03, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced details for its first Investor R&D Webinar. Management will describe the future promise of the company’s R&D pipeline, with...

SAN DIEGO, March 02, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced that it will release its fourth quarter 2021 financial results on Tuesday, March 22, 2022, after the market closes. In conjunction with th...

SAN DIEGO, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced that Todd R. Nelson, PhD, the company’s chief executive officer, will present virtually at the 42 nd Annual Cowen Healthcare Con...

The following slide deck was published by Codex DNA, Inc. in conjunction with this event. For further details see: Codex DNA (DNAY) Investor Presentation - Slideshow

SAN DIEGO, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced that members of its management team will be participating in the SVB Leerink 11 th Annual Global Healthcare Conference. An updated vers...

Despite double-digit gains today, Codex DNA (DNAY +22.7%) is still down ~38% from its IPO in June 2021. Its IPO was priced at $16. In afternoon trading today, shares stood at $9.33 Since the IPO, trading in Codex DNA has been volatile. Last month, Codex benefitted from a deal with Pfizer (PFE...

Gainers Bakkt Holdings (NYSE:BKKT) +30%. Kaival Brands Innovations Group (NASDAQ:KAVL) +29%. CF Acquisition (NASDAQ:CFVIU) +21%. CF Acquisition (NASDAQ:CFVI) +19%. Origin Agritech (NASDAQ:SEED) +20%. Phunware (NASDAQ:PHUN) +19%. IceCure Medical (NASDAQ:ICCM) +17%. Peloton Interactive (NASDAQ:...

Proprietary short oligo ligation assembly (SOLA) technology used to enzymatically synthesize DNA fragments for the construction of full-length H1 and N1 genes from influenza A virus Initial performance results show potentially significant quality, time, and cost advantages compa...

Pfizer and Codex DNA agree to strategic, multiyear, early access research collaboration, leveraging Codex DNA’s novel enzymatic DNA synthesis (EDS) technology Pfizer’s successful development and commercialization of licensed products could result in milestone pay...